ClinicalTrials.Veeva

Menu

GWAS Research of Lung Cancer in Tianjin

T

Tianjin Medical University

Status

Unknown

Conditions

Non-small Cell Lung Cancer
Primary Carcinoma

Study type

Observational

Funder types

Other

Identifiers

NCT01255059
TMU-CIH-GWASLC-Epi-Tianjin

Details and patient eligibility

About

To study the association of Genetic Polymorphisms with Lung Cancer Risk in Tianjin Population.

Full description

Eligibility criteria:

  • nonsmoker
  • female
  • age between 35 and 80
  • no other types of tumors history
  • frequency-matched cases and controls on gender and age

Outcome measures:

  • OR(odds ratio)
  • RR(risk ratio)
  • CI(confidence interval)
  • SAS software

Enrollment

500 estimated patients

Sex

Female

Ages

35 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Non-small cell lung cancer
  • Age from 35 to 80 years old
  • Female
  • Non-smokers
  • Frequency-matched on age and gender

Exclusion criteria

  • Previous medical history of cancer
  • Previous radiotherapy
  • Previous chemotherapy

Trial design

500 participants in 2 patient groups

Female lung cancer group
Description:
Female, non-smoker, non-small cell lung cancer
Health control
Description:
Female, non-smokers, no lung cancer or other types of cancers' healthy population

Trial contacts and locations

1

Loading...

Central trial contact

Chen Kexin, M.D., Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems